Preclinical development of combinations with CHK1 inhibitors in melanoma and lung cancer (2018–2019)

Grant type:
Cancer Council Queensland
Researchers:
  • Honorary Professor
    Mater Research Institute-UQ
    Faculty of Medicine
    Honorary Professor
    Mater Research Institute-UQ
    Faculty of Medicine
Funded by:
Cancer Council Queensland